Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

ClinicalTrials.gov ID: NCT06073119

Public ClinicalTrials.gov record NCT06073119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of Efficacy and Safety of SAR441566 in Adults With Moderate to Severe Plaque Psoriasis

Study identification

NCT ID
NCT06073119
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
221 participants

Conditions and interventions

Conditions

Interventions

  • SAR441566 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 25, 2023
Primary completion
Nov 12, 2024
Completion
Dec 10, 2024
Last update posted
Nov 9, 2025

2023 – 2024

United States locations

U.S. sites
11
U.S. states
5
U.S. cities
11
Facility City State ZIP Site status
Scottsdale Clinical Trials Site Number : 8400025 Scottsdale Arizona 85260
Dermatology Research Associates- Site Number : 8400019 Los Angeles California 90045
Daxia Trials Site Number : 8400022 Boca Raton Florida 33431
Renaissance Research and Medical Group, Inc- Site Number : 8400018 Cape Coral Florida 33991
Driven Research, LLC- Site Number : 8400012 Coral Gables Florida 33134
FXM Clinical Research Ft. Lauderdale, LLC Site Number : 8400015 Fort Lauderdale Florida 33308
Direct Helpers Medical Center Inc- Site Number : 8400023 Hialeah Florida 33012
FXM Clinical Research Miami, LLC- Site Number : 8400016 Miami Florida 33175
Center for Clinical Studies, LTD. LLP- Site Number : 8400007 Houston Texas 77004
Center for Clinical Studies, LTD, LLP- Site Number : 8400013 Webster Texas 77598
Jordan Valley Dermatology Center- Site Number : 8400027 South Jordan Utah 84095

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06073119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06073119 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →